Sensorium Therapeutics, Inc. — Form D

Sensorium Therapeutics, Inc. of MEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-12. The offering totals $38.5M, of which $14.5M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2025-02-12
Form: D
Accession: 0001874823-25-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $38.5M
Amount sold: $14.5M
Remaining: $24.0M
Investors: 4
Date of first sale: 2025-01-28
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-538071

Issuer

Name: Sensorium Therapeutics, Inc.
CIK: 0001874823
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 47 HIGH ST. #513, MEDFORD, MA, 02155
Phone: (339) 329-2333

Officers, directors & promoters (12)

Name	Role	Location
David Southwell	Director	NEW YORK, NY
Alexandra Glucksmann	Executive Officer	Medford, MA
Jerrold Rosenbaum	Director	Claymont, DE
Ryan Katz	Director	Medford, MA
Kevin Lalande	Director	Medford, MA
Richard Simon	Director	Medford, MA
Richard Simon	Executive Officer	Medford, MA
Balkrishan Gill	Director	Medford, MA
Alexandra Glucksmann	Director	Medford, MA
Jacob Hooker	Director	Medford, MA
Jacob Hooker	Executive Officer	Medford, MA
Pranav Tadi	Executive Officer	Boston, MA

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2025-07-15	D/A	$58.5M	$26.8M
2023-12-06	D/A	$24.8M	$24.7M
2022-10-04	D	$24.8M	$15.5M
2021-07-23	D	$9.0M	$9.0M

More